|
|
||||||||
Ann Thorac Surg 2003;75:1974-1976
© 2003 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
Accepted for publication November 26, 2002.
* Address reprint requests to Dr Moazami, Cardiac Transplantation, Washington University School of Medicine, Barnes-Jewish Hospital, Queeny Tower, Suite 3108, One Barnes-Jewish Hospital Plaza, St. Louis, MO 63110-1013, USA
e-mail: moazamin{at}msnotes.wustl.edu
Recombinant human B-type natriuretic peptide (BNP) is a promising new agent in the management of heart failure. The pharmacologic properties of BNP make it desirable to use in a subset of patients after cardiac surgical operations. Among these therapeutic potentials is the effect on markedly reducing pulmonary vascular resistance and central venous pressure with mild systemic vasodilatation. In addition, BNP directly effects the kidneys to promote natriuresis. We believe this agent to be useful in the treatment of the postcardiac surgery patients with left ventricular dysfunction and mild to moderate renal insufficiency. This report summarizes our experience in 2 patients.
This article has been cited by other articles:
![]() |
A. Dunn and S. Sachak Nesiritide and renal function after cardiac surgery Am. J. Health Syst. Pharm., August 1, 2007; 64(15): 1582 - 1584. [Full Text] [PDF] |
||||
![]() |
M. L Brackbill, M D. Stam, R. V Schuller-Williams, and A. A Dhavle Perioperative Nesiritide Versus Milrinone in High-Risk Coronary Artery Bypass Graft Patients Ann. Pharmacother., March 1, 2007; 41(3): 427 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Salzberg, F. Filsoufi, A. Anyanwu, K. von Harbou, A. Gass, S. P. Pinney, A. Carpentier, and D. H. Adams High-Risk Mitral Valve Surgery: Perioperative Hemodynamic Optimization with Nesiritide (BNP) Ann. Thorac. Surg., August 1, 2005; 80(2): 502 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Sun, C. Dominguez, N. A. Mallavaram, and J. M. Quaegebeur Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1104 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Samuels, E. C. Holmes, and L. Letwin Nesiritide as an adjunctive therapy in adult patients with heart failure undergoing high-risk cardiac surgery J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 627 - 629. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |